Marilyn Telen, MD, professor of medicine and chief of the Division of Hematology, recently learned that the NIH had renewed Duke's T-32 grant, for which she is program director.
That grant supports both Internal Medicine Hematology and Pediatric Hematology/Oncology research fellows (total of six per year) working in hematology, bone marrow transplant, and transfusion medicine, as well as one PhD post-doctoral trainee in hemoglobinopathies research.
This renewal is for years 36-40 of the grant, starting July 1, 2011. The grant was started in July 1975.
[toggle title_open="From the abstract: program description" title_closed="From the abstract: program description" hide="yes" border="yes" style="default" excerpt_length="0" read_more_text="Read More" read_less_text="Read Less" include_excerpt_html="no"]The purpose of the Training Program in Transfusion Medicine and Hematology is to provide research training in transfusion medicine and the scientific disciplines related to Hematology in order to develop academically oriented physician-scientists and nonphysician scientists with expertise in the performance of both basic and clinical research.
Upon completion of this program, each trainee will be qualified to assume a medical school faculty position and conduct an independent program of clinical or laboratory investigation in one of the fields of study included in this program, including Immunohematology and Transfusion Medicine (Track I); Hemoglobin, Hematopoiesis and Cellular Therapy (Track II); Coagulation and Thrombosis (Track III); and Molecular Biology, Molecular Signaling, and Genetics (Track IV).[/toggle]